Although older patients saw a greater rate of AE-related discontinuations, survival outcomes were similar between groups.
Antonio Ocejo, MD
Advertisement
Articles by Antonio Ocejo, MD
Despite differences in treatment tolerance across different RCC subgroups, survival outcomes were similar in a retrospective study.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Post-Surgery Nivolumab Shows No DFS Improvement in EGFR/ALK-Negative NSCLC
2
Linvoseltamab May Improve Outcomes Vs Teclistamab in R/R Multiple Myeloma
3
FLAME: Osimertinib Plus Chemotherapy Improves PFS in ctDNA-Persistent NSCLC
4
AI-Based Pathology Image Classifier May Elucidate AR Benefit in mHSPC
5